Antibody

New study tests how mutations in SARS-CoV-2 affect antibody neutralization

Antibodies to SARS-CoV-2 and RBD spike proteins found in saliva of mRNA vaccine recipients

It may be possible to delay the second dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in some cases.

Researchers are developing an assay for the qualitative evaluation of SARS-CoV-2 neutral antibodies

Nanobody works against all variants of SARS-CoV-2 stress in an animal model

Neutral antibodies may be developed to keep up with SARS-CoV-2 mutations

Tiny antibodies produced by llamas may be effective against COVID-19

A single dose of the SARS-CoV-2 vaccine candidate stimulates a neutralization response in COVID-19 convalescents

New variants of COVID-19 can avoid antibodies that work against the original form of the virus

Preclinical study finds immunosuppressive benefit in Soligenix coronavirus inseparable vaccines